Search

Your search keyword '"Spivak NIa"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Spivak NIa" Remove constraint Author: "Spivak NIa"
76 results on '"Spivak NIa"'

Search Results

1. Nanocrystalline ceria based materials—Perspectives for biomedical application

2. [Gene-engineering technologies and stem cells]

3. [Mesenchymal progenitor cells. Biological characteristic and prospects for their use]

4. [The lysate and recombinant antigens in ELISA-test-systems for diagnostic of herpes simplex].

5. [Simultaneous quantification of soluble fibrin and D-dimer in blood plasma for the assessment of the threat of thrombosis].

6. [Production of purified human recombinant alpha2b-interferon].

7. [Obtaining of hairy-root, callus and suspension carrot culture (Daucus carota L.) able to accumulate human interferon alpha-2b].

8. [Nanocrystaline ceria based materials--perspectives for biomedical application].

9. [Influence of physiological state of Escherichia coli cells on the expression of soluble protein--recombinant analog of glycoprotein G of Herpes simplex virus of type 2].

10. [Antiviral effect of cerium dioxide nanoparticles stabilized by low-molecular polyacrylic acid].

11. [Thrombin inhibitors which display antibacterial activity].

12. [The role of Toll-like receptors in regulation of immune responses in norm and pathology].

13. [Interferon-stimulating activity of muramoyl dipeptide glycosides].

14. [Optimization of microbial synthesis of recombinant analogs of Treponema pallidum membrane proteins (Tpp17 and Tpp47) and estimation of their immunochemical properties].

15. [Mesenchymal progenitor cells. Biological characteristic and prospects for their use].

16. [Preparation of monoclonal antibodies to the Fc-fragment of human IgG and the use of their based immunoenzyme conjugates].

17. [Functional activity of lymphoblastoid cells infected by human adenovirus type 2 and Epstein-Barr virus].

18. [Specific immunoglobulins as effective drugs for treatment of virus infections: present state and urgent tasks in Ukraine].

19. [Effect of synthetic muramyl dipeptide derivatives on staphylococcal infection in mice].

20. [The antibacterial efficacy of preparations of interferon and its inducers].

21. [Study of the inhibiting effect of the molecular complex yeast RNA-tilorone on HIV-1 reproduction in vitro].

22. [The immune response in HIV infection and associated diseases of the female genitalia].

23. [The immunocorrection with Aerosil-350 of the natural resistance of mice found under conditions of an elevated radiation background].

24. [Study of anti-HIV activity of the yeast RNA-tilorone molecular complex].

25. [Immunomodulating effects of alpha-interferon in Pseudomonas aeruginosa infection].

26. [Cytokines and nonviral infections].

27. [Synergistic action of recombinant preparations of gamma-interferon and tumor necrosis factor on the course of experimental staphylococcal infection].

28. [Disorders of interferon status in bronchopulmonary diseases in children living under conditions of elevated background radiation].

29. [The effect of staphylococcal peptidoglycan on macrophage interferon formation and bactericidal activity].

30. [The efficacy of leukinferon in suppurative-septic diseases].

31. [Gamma-interferon and the antibacterial activity of mouse macrophages in a Salmonella infection].

32. [Interferon therapy of acute pneumonia in infants].

33. [The isolation and purification of porcine interferon-gamma].

34. [Intrapleural sorption detoxication in the combined treatment of acute destructive pneumonia in children].

35. [Effects of alpha-interferon on the level of adenosine metabolism enzymes and bactericidal activity of macrophages in staphylococcal infection].

36. [Antibacterial effects of gamma-interferon in experimental Klebsiella infection].

37. [Effects of interferon preparations on the course of Salmonella infection (experimental and clinical studies)].

38. [Interferon type I in protective body reactions in an experimental Klebsiella infection].

39. [The effect of leukinferon on the activity of phagocytosing cells in human salmonellosis].

40. [The protective action of interferon type I in experimental Salmonella infection].

41. [Effect of type I interferon on the course of endotoxic shock].

42. [Effect of interferon on the course of experimental E coli-induced pyelonephritis].

44. [Interferon inhibition of the development of a staphylococcal infection].

45. [Various properties of virulent and moderate Erwinia carotovora phages].

47. [Antitoxic activity of interferon preparations].

48. [Effect of interferon type I on the in vivo persistence of Salmonella typhimurium].

49. [The effect of alpha/beta and gamma interferon preparations on the functional activity of macrophages in experimental staphylococcal infections].

Catalog

Books, media, physical & digital resources